News › Clinical Practice, Industry News, Patient Care

FDA Approves Juvéderm Voluma XC for Enhancement of the Chin Region

June 15, 2020

Allergan Aesthetics, an AbbVie company, announced the FDA approval of Juvéderm Voluma XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21.1 The Juvéderm collection of fillers has a broad portfolio of specifically tailored treatment options, and this latest approval marks its fifth approved indication in the U.S.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • PracticeQ Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Fresh Clinics Acquires Spakinect
    • Arkansas Nursing Board Comment Deadline Approaching for Medical Aesthetics and IV Hydration Guidance
    • Acquisition Lets AI and Operators Learn From Nearly $2 Billion in Annual Aesthetics Transactions
    • Longevity, Safety, and Innovation: Merz Aesthetics on Natural Results and the Future of Regenerative Aesthetics
Advertisement